Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) stock price, news, charts, stock research, profile.
Open | $17.710 |
Close | - |
Volume / Avg. | 291.969K / 367.556K |
Day Range | 17.500 - 18.110 |
52 Wk Range | 10.645 - 22.090 |
Market Cap | $1.243B |
P/E Ratio | 137.385 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 8.78% |
Days to Cover | 9.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ: KNSA) through any online brokerage.
Other companies in Kiniksa Pharmaceuticals’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA), Immatics (NASDAQ:IMTX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
The latest price target for Kiniksa Pharmaceuticals (NASDAQ: KNSA) was reported by Evercore ISI Group on Wednesday, April 24, 2024. The analyst firm set a price target for 30.00 expecting KNSA to rise to within 12 months (a possible 67.08% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $17.955 last updated Today at April 25, 2024 at 3:21 PM EDT.
There are no upcoming dividends for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, July 23, 2024.
There is no upcoming split for Kiniksa Pharmaceuticals.
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.